https://www.selleckchem.com/pr....oducts/Dapagliflozin
The prototype model captures two physiologically relevant outcomes following infection a "healthy" immune response that appropriately defends against the virus, and an uncontrolled alveolar inflammatory response that is characteristic of acute respiratory distress syndrome. We aim to significantly shorten the typical QSP model development and validation timeline by encouraging community use, testing, and refinement of this prototype model. It is our expectation that the model will be further advanced in an open science approach (i
Like
Comment
Share
